Jenburkt Pharmaceuticals
NSE: JENBURPH · ISIN INE354A01013 · Healthcare
₹951.35−22.65 (−2.33%)
Monday 9 November, 12:41 IST. Delayed. Source: Yahoo Finance.
Price chart
₹951.35 −22.65 (−2.33%) today
The day
- Previous close
- ₹974.00
- Open
- ₹980.00
- Day high
- ₹980.00
- Day low
- ₹951.20
Listed on NSE since 17 August 2026.
Key numbers
- Market value
- ₹429.86 Cr
- P/E (trailing)
- 13.09
- EPS (trailing)
- ₹74.39
- Price to book
- 2.18
- Dividend yield
- 2.32%
- Debt to equity
- 0.01
- Profit margin
- 19.5%
- Beta
- 0.40
- Volume today
- 250
- Average volume
- 1,743
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹136.14 Cr | ₹24.61 Cr |
| FY24 | ₹141.63 Cr | ₹25.98 Cr |
| FY25 | ₹151.37 Cr | ₹32.06 Cr |
| FY26 | ₹168.31 Cr | ₹34.74 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
Quarterly results are unavailable from NSE right now, or none are on file for this company.
Balance sheet
The balance sheet is unavailable from NSE right now, or none is on file for this company.
About Jenburkt Pharmaceuticals
Jenburkt Pharmaceuticals Limited manufactures and markets pharmaceutical formulations in India and internationally. The company offers therapeutic solutions, such as analgesic and antipyretics, anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants and antacids, aphrodisiac, atopic dermatitis, consumer division, cough and cold, muscle relaxants, neuropathic pain, nutraceuticals, and pain management. It offers its products under the Allerzine, CartiSafe Forte, Crisbo, Eberjen, ECOPROT, Frendacid, Fundu, Glajen-E, GLUCOTROL, HYBRITA, Jenflam, La-Viril, LUMA, Lubtriben, Metmin, Nervega-75, Nervijen P, Nervijen, NOCAL, Numox-625, OJEN, ORNEL, Oxicojen, PANTAZOLE, PIRITEXYL, POWERDOL, Powergesic, Rabera, Topcal-M, Trapidol-D, TREGA, TRIBEN, ZENGLOBIN, ZIX, Zix-MR, Zix-PG 200/75, and Zydol Suspension brand names. The company also exports its products. It serves large government, semi-government institutions, missionary hospitals, and public sector enterprises. Jenburkt Pharmaceuticals Limited was incorporated in 1985 and is based in Mumbai, India.
- Industry
- Drug Manufacturers - Specialty & Generic
- Based in
- Mumbai
- Employees
- 801
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Jenburkt Pharmaceuticals in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 20.70 Per Share
Dividend · ex-date 28 August 2026
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.